Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

ATNM

ATNM News

Newswire

10:30

Actinium Pharmaceuticals Presents New Preclinical Data for ATNM-400, Demonstrating Potent Anti-Tumor Activity and Favorable Tolerability Profile in Breast Cancer Models.

08:57

Actinium Pharmaceuticals presents preclinical data for ATNM-400 at SABCS.

04:06

Eckert & Ziegler shares surge 11.59% premarket after signing Actinium-225 supply agreement with SK Biopharmaceuticals.

09:03

Actinium shares surge 14.49% premarket after ATNM-400 data presented at SABCS shows efficacy in resistant breast cancer.

09:00

Actinium Pharmaceuticals presents preclinical data for ATNM-400 breast cancer treatment.

View More

About ATNM

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More